search
Back to results

Comparison of Outcomes and Access to Care for Heart Failure Trial (COACH)

Primary Purpose

Heart Failure

Status
Completed
Phase
Phase 3
Locations
Canada
Study Type
Interventional
Intervention
Risk stratification and transitional care intervention
Sponsored by
Institute for Clinical Evaluative Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Heart Failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient presenting to an emergency department with heart failure

Exclusion Criteria:

  • Palliative or DNR
  • Dialysis dependent
  • Non-Ontario resident

Sites / Locations

  • Toronto Genera Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Active Intervention

Control

Arm Description

Two components to the intervention: (1) clinical algorithm for prognostication, and (2) post-discharge follow-up in the RAPID-HF clinic Intervention #1 - Clinical algorithm: the EHMRG30-ST risk score which will be used to categorize patients as high, intermediate, or low risk. The clinical algorithm will be used to guide clinicians to decide on admission to hospital, observation during a short stay hospital admission (3 days or less), or emergency department discharge. Intervention #2 - Referral to RAPID-HF (Rapid Ambulatory Program for Investigation and Diagnosis of HF) transitional care clinic: visit to RAPID-HF within 48-72 hours of discharge. Care provided in RAPID-HF by cardiologist + nurse for up to 30 days from date of discharge.

Usual care without access to the EHMRG30-ST scoring system, decision algorithm, or RAPID-HF clinic.

Outcomes

Primary Outcome Measures

Co-primary outcome: 30 day early events
Time to composite of death or cardiovascular hospitalization (nonelective, los > 1 day)
Co-primary outcome: 20 month extended events
Time to composite of death or cardiovascular hospitalization (nonelective, los > 1 day)

Secondary Outcome Measures

All-cause death
Time to death
Cardiovascular hospitalization
Time to cardiovascular hospitalization (nonelective, los > 1 day)
Heart failure hospitalization
Time to heart failure hospitalization (nonelective, los > 1 day)
All-cause death
Time to death (nonpalliative)
Cardiovascular hospitalization
Time to cardiovascular hospitalization (nonelective, los > 1 day)
Heart failure hospitalization
Time to heart failure hospitalization (nonelective, los > 1 day)

Full Information

First Posted
January 29, 2016
Last Updated
October 4, 2022
Sponsor
Institute for Clinical Evaluative Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT02674438
Brief Title
Comparison of Outcomes and Access to Care for Heart Failure Trial
Acronym
COACH
Official Title
Comparison of Outcomes and Access to Care for Heart Failure Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
September 2016 (Actual)
Primary Completion Date
December 1, 2021 (Actual)
Study Completion Date
August 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institute for Clinical Evaluative Sciences

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Heart failure is a condition where the heart pump does not function normally causing the lungs to become congested. The primary symptom of heart failure is shortness of breath, and this often leads to patients visiting the emergency department for care. Decision-making in the emergency department is a high-stakes situation, where there is a need for decision support to guide clinicians to make better decisions about admission to hospital or discharge home. Many low-risk patients who could potentially be managed at home are admitted to hospital whereas some patients who are thought safe to discharge are actually high risk and will have adverse outcomes if they are discharged home from the emergency department. In this trial, the investigators will study a new strategy for heart failure care, comprised of a computer algorithm to help doctors make decisions in the emergency department about the risk of their patient. For low-risk patients who are discharged home from the emergency department or after a short hospital stay, patients will be referred to a rapid follow-up clinic where the heart specialist team will rapidly assess and treat patients.
Detailed Description
Overview: Randomized intervention trial to examine the impact of an acute heart failure strategy, which incorporates risk stratification and rapid outpatient care after discharge. Study Population: Patients presenting to the emergency department with heart failure will be eligible for study inclusion. Inclusion and Exclusion Criteria for the Study: Age 18 years or older Presents to the emergency department with acute heart failure diagnosed clinically and verified by a primary diagnosis of heart failure (ICD-10-CA code I50) on the emergency department facesheet. Exclusion criteria: Does not meet Framingham criteria for heart failure Heart failure diagnosis unlikely according to B-type natriuretic peptide values BNP <100 pg/mL or NT-proBNP <300 pg/mL End stage renal disease on dialysis Palliative patient with do not resuscitate (DNR) order present prior to emergency department arrival Limited mobility to attend outpatient clinic visits Dementia Nursing home resident No permanent home address Non-resident of Ontario Self-discharge from emergency department Invalid Ontario health insurance number Inclusion and Exclusion Criteria for the RAPID-HF Clinic: Inclusion criteria: Patients with heart failure presenting to the emergency department meeting overall study eligibility criteria Discharged at any time within the first 3 days after emergency department presentation Using the EHMRG30-ST risk score: Any low-risk patient who is able to be discharged within 3 days of initial emergency department presentation Some intermediate-to-low risk zone EHMRG30-ST may be eligible if judged to be clinically stable Patient agrees to be discharged early from either the emergency department or hospital Able to attend outpatient clinic visits Exclusion criteria: High risk zone of EHMRG30-ST Pre-cardiac transplant Active cardiac ischemia without diagnostic testing done during hospital stay Uncontrolled arrhythmia Worsening renal failure compared to baseline renal function Significant abnormality of vital signs at the time of referral: Oxygen saturation on room air less than or equal to 90% which is not usual for patient Systolic blood pressure < 90 mmHg with symptoms of hypotension Heart rate in sinus rhythm greater than or equal to 100 bpm Respiratory rate > 20 breaths/minute New heart failure diagnosis (not an absolute contraindication to referral, but not recommended) Intervention: The study involves 2 components: clinical algorithm for prognostication and post-discharge follow-up in the Rapid Ambulatory Program for Investigation and Diagnosis of Heart Failure (RAPID-HF) clinic. The clinical decision-support algorithm intervention is a composite of 7-day and 30-day risk calculator (called EHMRG30-ST). Using the EHMRG30-ST algorithm, patients will be categorized as high, intermediate, or low risk. The decision support algorithm will recommend hospital admission or discharge/observation based on patient risk to assist clinicians making the final decision to admit or discharge. Low risk patients may be discharged early (within 3 days of initial presentation) and referred to the RAPID-HF clinic. Patients referred to RAPID-HF will be assessed ideally within 48-72 hours of discharge. RAPID-HF provides transitional care for up to 30 days after discharge. After 30-days, care is transferred to primary care provider or specialist for ongoing care. Study Design: Using a stepped-wedge design, participating sites will be randomized to the active intervention. At each step, hospitals that have not yet been randomized will serve as control sites.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
5452 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active Intervention
Arm Type
Experimental
Arm Description
Two components to the intervention: (1) clinical algorithm for prognostication, and (2) post-discharge follow-up in the RAPID-HF clinic Intervention #1 - Clinical algorithm: the EHMRG30-ST risk score which will be used to categorize patients as high, intermediate, or low risk. The clinical algorithm will be used to guide clinicians to decide on admission to hospital, observation during a short stay hospital admission (3 days or less), or emergency department discharge. Intervention #2 - Referral to RAPID-HF (Rapid Ambulatory Program for Investigation and Diagnosis of HF) transitional care clinic: visit to RAPID-HF within 48-72 hours of discharge. Care provided in RAPID-HF by cardiologist + nurse for up to 30 days from date of discharge.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual care without access to the EHMRG30-ST scoring system, decision algorithm, or RAPID-HF clinic.
Intervention Type
Other
Intervention Name(s)
Risk stratification and transitional care intervention
Intervention Description
Intervention consists of 2 components: Risk stratification: Determination of risk using the EHMRG 7-day and 30-day risk scores (EHMRG30-ST), where decision to admit, observe, or discharge the patient will be guided by the result of the risk scores Transitional care: Follow-up care in the RAPID-HF transitional care clinic begins at 48-72 hours after emergency department or hospital discharge. Care provided by cardiologist + nurse for up to 30 days after emergency department or hospital discharge.
Primary Outcome Measure Information:
Title
Co-primary outcome: 30 day early events
Description
Time to composite of death or cardiovascular hospitalization (nonelective, los > 1 day)
Time Frame
30 days
Title
Co-primary outcome: 20 month extended events
Description
Time to composite of death or cardiovascular hospitalization (nonelective, los > 1 day)
Time Frame
20 month follow-up
Secondary Outcome Measure Information:
Title
All-cause death
Description
Time to death
Time Frame
30 days
Title
Cardiovascular hospitalization
Description
Time to cardiovascular hospitalization (nonelective, los > 1 day)
Time Frame
30 days
Title
Heart failure hospitalization
Description
Time to heart failure hospitalization (nonelective, los > 1 day)
Time Frame
30 days
Title
All-cause death
Description
Time to death (nonpalliative)
Time Frame
20 months
Title
Cardiovascular hospitalization
Description
Time to cardiovascular hospitalization (nonelective, los > 1 day)
Time Frame
20 months
Title
Heart failure hospitalization
Description
Time to heart failure hospitalization (nonelective, los > 1 day)
Time Frame
20 months
Other Pre-specified Outcome Measures:
Title
Patient-centered outcome
Description
Time to nonelective emergency department visit (CTAS 1-4), death or cardiovascular hospitalization
Time Frame
1) 30-day and 2) 20 month
Title
Early discharge
Description
Proportion of patients discharged within 3 days of emergency presentation
Time Frame
3 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient presenting to an emergency department with heart failure Exclusion Criteria: Palliative or DNR Dialysis dependent Non-Ontario resident
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Douglas Lee, MD, PhD
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Toronto Genera Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G2C4
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Due to Ontario privacy regulations, unable to share data
Citations:
PubMed Identifier
36342109
Citation
Lee DS, Straus SE, Farkouh ME, Austin PC, Taljaard M, Chong A, Fahim C, Poon S, Cram P, Smith S, McKelvie RS, Porepa L, Hartleib M, Mitoff P, Iwanochko RM, MacDougall A, Shadowitz S, Abrams H, Elbarasi E, Fang J, Udell JA, Schull MJ, Mak S, Ross HJ; COACH Trial Investigators. Trial of an Intervention to Improve Acute Heart Failure Outcomes. N Engl J Med. 2023 Jan 5;388(1):22-32. doi: 10.1056/NEJMoa2211680. Epub 2022 Nov 5.
Results Reference
derived

Learn more about this trial

Comparison of Outcomes and Access to Care for Heart Failure Trial

We'll reach out to this number within 24 hrs